Bendamustine hydrochloride (bendamustine hydrochloride)
(bendamustine hydrochloride)Baxter Healthcare Corporation
Usage: Bendamustine Hydrochloride Injection is indicated for treating adult patients with chronic lymphocytic leukemia (CLL) and for indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of rituximab therapy. Efficacy against other first-line treatments has not been established.